Literature DB >> 32484508

Adverse Outcomes in Pregnant Women Hospitalized With Respiratory Syncytial Virus Infection: A Case Series.

Anne M Hause1,2, Lakshmi Panagiotakopoulos1, Eric S Weintraub1, Lina S Sy3, Sungching C Glenn3, Hung-Fu Tseng3, Michael M McNeil1.   

Abstract

We identified 10 women hospitalized with respiratory syncytial virus infection during pregnancy. Diagnoses included pneumonia/atelectasis (5), respiratory failure (2), and sepsis (2). Six had obstetrical complications during hospitalization, including 1 induced preterm birth. One required intensive care unit admission and mechanical ventilation. Four infants had complications at birth. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  maternal infections; maternal vaccines; pregnancy; respiratory infections; respiratory syncytial virus

Year:  2021        PMID： 32484508      PMCID： PMC7823066          DOI： 10.1093/cid/ciaa668

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  15 in total

Review 1.  Influenza, immune system, and pregnancy.

Authors:  Renju S Raj; Elizabeth A Bonney; Mark Phillippe
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

2.  Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women.

Authors:  Linda Dodds; Shelly A McNeil; Deshayne B Fell; Victoria M Allen; Ann Coombs; Jeffrey Scott; Noni MacDonald
Journal:  CMAJ       Date:  2007-02-13       Impact factor: 8.262

3.  Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.

Authors:  Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

4.  A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

Authors:  Gregory M Glenn; Louis F Fries; D Nigel Thomas; Gale Smith; Eloi Kpamegan; Hanxin Lu; David Flyer; Dewal Jani; Somia P Hickman; Pedro A Piedra
Journal:  J Infect Dis       Date:  2015-08-10       Impact factor: 5.226

5.  Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.

Authors:  Allison L Naleway; Rachel Gold; Samantha Kurosky; Karen Riedlinger; Michelle L Henninger; James D Nordin; Elyse O Kharbanda; Stephanie Irving; T Craig Cheetham; Natalie L McCarthy
Journal:  Vaccine       Date:  2013-04-30       Impact factor: 3.641

6.  Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy.

Authors:  Sarahn M Wheeler; Sarah Dotters-Katz; R Phillip Heine; Chad A Grotegut; Geeta K Swamy
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

7.  Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study.

Authors:  Shabir A Madhi; Clare L Cutland; Sarah Downs; Stephanie Jones; Nadia van Niekerk; Eric A F Simoes; Marta C Nunes
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

Review 8.  Emerging infections and pregnancy.

Authors:  Denise J Jamieson; Regan N Theiler; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

9.  Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study.

Authors:  Liling Chaw; Taro Kamigaki; Alexanderyn Burmaa; Chuluunbatiin Urtnasan; Ishiin Od; Gunregjaviin Nyamaa; Pagbajabyn Nymadawa; Hitoshi Oshitani
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  A Cross-sectional Surveillance Study of the Frequency and Etiology of Acute Respiratory Illness Among Pregnant Women.

Authors:  Anne M Hause; Vasanthi Avadhanula; Maurizio L Maccato; Phillip M Pinell; Nanette Bond; Patricia Santarcangelo; Laura Ferlic-Stark; Flor M Munoz; Pedro A Piedra
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226
View more
  3 in total

1.  Maternal RSV vaccine development. Where to from here?

Authors:  Ahinsa Gunatilaka; Michelle L Giles
Journal:  Hum Vaccin Immunother       Date:  2021-09-09       Impact factor: 4.526

2.  Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study.

Authors:  Marcin Januszewski; Laura Ziuzia-Januszewska; Alicja A Jakimiuk; Waldemar Wierzba; Anna Gluszko; Joanna Zytynska-Daniluk; Artur J Jakimiuk
Journal:  Int J Environ Res Public Health       Date:  2021-11-16       Impact factor: 3.390

Review 3.  Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection.

Authors:  Catalina A Andrade; Alexis M Kalergis; Karen Bohmwald
Journal:  Pathogens       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.